Annual Accounts Receivable
$2.56 B
+$330.00 M+14.81%
December 1, 2024
Summary
- As of February 24, 2025, BSX annual accounts receivable is $2.56 billion, with the most recent change of +$330.00 million (+14.81%) on December 1, 2024.
- During the last 3 years, BSX annual accounts receivable has risen by +$780.00 million (+43.87%).
- BSX annual accounts receivable is now at all-time high.
Performance
BSX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
December 1, 2024
Summary
- BSX quarterly accounts receivable is not available.
Performance
BSX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BSX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.8% | - |
| 3 y3 years | +43.9% | - |
| 5 y5 years | +39.9% | - |
BSX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.9% | ||
| 5 y | 5-year | at high | +67.1% | ||
| alltime | all time | at high | +3310.7% |
Boston Scientific Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.56 B(+14.8%) | - |
| Sep 2024 | - | $2.50 B(+4.2%) |
| Jun 2024 | - | $2.40 B(+4.2%) |
| Mar 2024 | - | $2.30 B(+3.4%) |
| Dec 2023 | $2.23 B(+13.1%) | $2.23 B(+6.0%) |
| Sep 2023 | - | $2.10 B(-1.5%) |
| Jun 2023 | - | $2.13 B(+2.8%) |
| Mar 2023 | - | $2.08 B(+5.4%) |
| Dec 2022 | $1.97 B(+10.8%) | $1.97 B(+5.3%) |
| Sep 2022 | - | $1.87 B(-2.4%) |
| Jun 2022 | - | $1.92 B(+2.7%) |
| Mar 2022 | - | $1.87 B(+4.9%) |
| Dec 2021 | $1.78 B(+16.1%) | $1.78 B(+6.5%) |
| Sep 2021 | - | $1.67 B(-0.4%) |
| Jun 2021 | - | $1.68 B(+2.7%) |
| Mar 2021 | - | $1.63 B(+6.5%) |
| Dec 2020 | $1.53 B(-16.2%) | $1.53 B(-4.2%) |
| Sep 2020 | - | $1.60 B(+9.7%) |
| Jun 2020 | - | $1.46 B(-7.6%) |
| Mar 2020 | - | $1.58 B(-13.7%) |
| Dec 2019 | $1.83 B(+13.7%) | $1.83 B(+1.8%) |
| Sep 2019 | - | $1.80 B(+4.9%) |
| Jun 2019 | - | $1.71 B(+5.6%) |
| Mar 2019 | - | $1.62 B(+0.8%) |
| Dec 2018 | $1.61 B(+3.9%) | $1.61 B(+1.8%) |
| Sep 2018 | - | $1.58 B(-0.4%) |
| Jun 2018 | - | $1.59 B(+0.4%) |
| Mar 2018 | - | $1.58 B(+2.1%) |
| Dec 2017 | $1.55 B(+5.2%) | $1.55 B(+5.3%) |
| Sep 2017 | - | $1.47 B(+1.8%) |
| Jun 2017 | - | $1.44 B(+1.0%) |
| Mar 2017 | - | $1.43 B(-2.9%) |
| Dec 2016 | $1.47 B(+15.5%) | $1.47 B(+6.3%) |
| Sep 2016 | - | $1.39 B(-0.1%) |
| Jun 2016 | - | $1.39 B(+7.4%) |
| Mar 2016 | - | $1.29 B(+1.3%) |
| Dec 2015 | $1.27 B(+7.8%) | $1.27 B(+0.1%) |
| Sep 2015 | - | $1.27 B(+6.6%) |
| Jun 2015 | - | $1.20 B(+2.9%) |
| Mar 2015 | - | $1.16 B(-1.9%) |
| Dec 2014 | $1.18 B(-9.5%) | $1.18 B(-4.1%) |
| Sep 2014 | - | $1.23 B(-4.2%) |
| Jun 2014 | - | $1.29 B(+5.8%) |
| Mar 2014 | - | $1.22 B(-6.9%) |
| Dec 2013 | $1.31 B(+7.4%) | $1.31 B(+5.6%) |
| Sep 2013 | - | $1.24 B(-3.1%) |
| Jun 2013 | - | $1.28 B(+3.7%) |
| Mar 2013 | - | $1.23 B(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.22 B(-2.3%) | $1.22 B(+1.7%) |
| Sep 2012 | - | $1.20 B(-3.7%) |
| Jun 2012 | - | $1.24 B(-5.5%) |
| Mar 2012 | - | $1.32 B(+5.6%) |
| Dec 2011 | $1.25 B(-5.6%) | $1.25 B(+0.7%) |
| Sep 2011 | - | $1.24 B(-7.3%) |
| Jun 2011 | - | $1.33 B(-0.1%) |
| Mar 2011 | - | $1.34 B(+1.2%) |
| Dec 2010 | $1.32 B(-4.0%) | $1.32 B(+0.4%) |
| Jun 2010 | - | $1.31 B(+1.1%) |
| Mar 2010 | - | $1.30 B(-5.4%) |
| Dec 2009 | $1.38 B(-1.9%) | $1.38 B(-3.9%) |
| Sep 2009 | - | $1.43 B(-0.9%) |
| Jun 2009 | - | $1.44 B(+5.5%) |
| Mar 2009 | - | $1.37 B(-2.4%) |
| Dec 2008 | $1.40 B(-6.7%) | $1.40 B(+3.5%) |
| Sep 2008 | - | $1.35 B(-4.3%) |
| Jun 2008 | - | $1.42 B(-5.3%) |
| Mar 2008 | - | $1.50 B(-0.4%) |
| Dec 2007 | $1.50 B(+7.4%) | $1.50 B(+1.0%) |
| Sep 2007 | - | $1.49 B(-1.4%) |
| Jun 2007 | - | $1.51 B(+5.1%) |
| Mar 2007 | - | $1.44 B(+2.6%) |
| Dec 2006 | $1.40 B(+50.0%) | $1.40 B(-4.2%) |
| Sep 2006 | - | $1.46 B(-3.9%) |
| Jun 2006 | - | $1.52 B(+55.3%) |
| Mar 2006 | - | $978.00 M(+4.9%) |
| Dec 2005 | $932.00 M(+3.6%) | $932.00 M(-2.0%) |
| Sep 2005 | - | $951.00 M(-2.6%) |
| Jun 2005 | - | $976.00 M(+2.4%) |
| Mar 2005 | - | $953.00 M(+5.9%) |
| Dec 2004 | $900.00 M(+66.1%) | $900.00 M(+6.4%) |
| Sep 2004 | - | $846.00 M(+3.9%) |
| Jun 2004 | - | $814.00 M(+20.6%) |
| Mar 2004 | - | $675.00 M(+24.5%) |
| Dec 2003 | $542.00 M(+24.6%) | $542.00 M(+6.7%) |
| Sep 2003 | - | $508.00 M(+6.3%) |
| Jun 2003 | - | $478.00 M(+5.8%) |
| Mar 2003 | - | $452.00 M(+3.9%) |
| Dec 2002 | $435.00 M(+17.6%) | $435.00 M(+9.0%) |
| Sep 2002 | - | $399.00 M(-1.7%) |
| Jun 2002 | - | $406.00 M(+7.1%) |
| Mar 2002 | - | $379.00 M(+2.4%) |
| Dec 2001 | $370.00 M(+393.3%) | $370.00 M(-5.4%) |
| Sep 2001 | - | $391.00 M(+3.7%) |
| Jun 2001 | - | $377.00 M(+1.9%) |
| Mar 2001 | - | $370.00 M(+393.3%) |
| Dec 1994 | $75.00 M | $75.00 M |
FAQ
- What is Boston Scientific annual accounts receivable?
- What is the all time high annual accounts receivable for Boston Scientific?
- What is Boston Scientific annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for Boston Scientific?
What is Boston Scientific annual accounts receivable?
The current annual accounts receivable of BSX is $2.56 B
What is the all time high annual accounts receivable for Boston Scientific?
Boston Scientific all-time high annual accounts receivable is $2.56 B
What is Boston Scientific annual accounts receivable year-on-year change?
Over the past year, BSX annual accounts receivable has changed by +$330.00 M (+14.81%)
What is the all time high quarterly accounts receivable for Boston Scientific?
Boston Scientific all-time high quarterly accounts receivable is $2.50 B